Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro

Table 1

In vitro antiviral assay.

	CC50	EC90	SI90
Metadichol (μg/mL)	4	0.15	20
M128533 (μg/mL)	>10	0.2	>33

CC₅₀: 50% cytotoxic concentration of compound without virus added; EC₅₀: 50% effective antiviral concentration; EC₉₀: calculated concentration to reduce viral yield by 1 log (90%); SI: CC₅₀/EC₅₀.